Home > Healthcare > Medical Devices > Therapeutic Devices > Sex Reassignment Surgery (SRS) Market

Sex Reassignment Surgery (SRS) Market Analysis

  • Report ID: GMI2926
  • Published Date: Jul 2024
  • Report Format: PDF

Sex Reassignment Surgery Market Analysis

Based on gender transition, the market is segmented into male to female and female to male. The male to female segment is further classified into facial, breast, and genital segments. The male to female segment dominated the market in 2023 and accounted for USD 369.9 million.

 

  • The male to female surgery prominence is due to the high prevalence of gender dysphoria among males which is prompting greater adoption of male-to-female surgeries, thereby stimulating market expansion.

     

  • For instance, a Scientific Reports article - "Validity of the Gender Dysphoria Diagnosis and Incidence Trends in Sweden: A Nationwide Register Study," published in August 2021, reported that the overall prevalence in the studied population in Europe, the U.S., and Australia for gender dysphoria was 0.46 per 10,000 population, with 0.68 for birth-assigned males and 0.26 for birth-assigned females. Such a high prevalence of gender dysphoria in males drives the adoption of sex reassignment surgeries in males, thereby propelling the segment growth.

 

North America Sex Reassignment Surgery Market, 2021 – 2032 (USD Million)

North America dominated the global sex reassignment surgery market in 2023 with a market share of 37.3% and is anticipated to grow at a CAGR of 8.4% between 2024 – 2032.

 

  • The region’s dominance was asserted to the rising prevalence of gender dysphoria, increasing awareness, high adoption of gender reassignment surgery, and support from government and public organizations.

     

  • For instance, a CDC article titled "Transgender and Gender Diverse Persons," in July 2021, reported that approximately 9,000 transgender surgeries are being performed annually in the U.S.

     

  • Furthermore, government backing, such as financial support for surgical procedures, further enhances the market expansion.

     

  • For instance, in June 2021, VA Secretary Denis McDonough announced that the U.S. government would offer gender confirmation surgery for transgender veterans through its health care coverage for the first time, previously covering only hormone replacement therapy and mental health services. These government initiatives contributed to the market growth in North America region.

     

U.S. sex reassignment surgery market is anticipated to grow at a CAGR of 7% between 2024 - 2032.

 

  • One primary driver is the increasing societal acceptance and legal support for transgender rights, which has encouraged more individuals to pursue gender-affirming surgeries.

     

  • Additionally, advancements in surgical techniques and postoperative care have improved the safety and outcomes of these procedures, attracting more patients.

     

  • Moreover, robust health insurance coverage for gender-affirming treatments, including surgeries, has made these procedures more accessible to a broader population. Thus, as awareness and support for transgender healthcare continue to grow, the U.S. is likely to maintain its leading position in this market.

     

Germany is anticipated to witness robust growth in the global sex reassignment surgery market.

 

  • Germany's market exhibits significant growth potential, driven by progressive healthcare policies, increased societal acceptance of transgender individuals, and advancements in medical technology.

     

  • The country's robust healthcare infrastructure and skilled medical professionals attract patients from both domestic and international locations.

     

  • Additionally, comprehensive insurance coverage for gender-affirming surgeries under the public health system reduces financial barriers, encouraging more individuals to undergo these procedures, thereby enhancing the market's expansion.

     

Asia Pacific region is anticipated to witness high growth in sex reassignment surgery market, growing at a CAGR of 13.9% over the analysis years.

 

  • Asia Pacific is positioned for substantial growth in the market due to evolving societal attitudes, increasing awareness about transgender healthcare needs, and improving medical tourism.

     

  • Countries like Thailand, known for its advanced medical facilities and skilled surgeons, have become global hubs for sex reassignment procedures, attracting individuals from various parts of the world. This influx is further bolstered by relatively lower costs compared to Western countries, making the region a preferred destination for affordable yet high-quality surgeries.

     

  • Furthermore, government support and progressive policies in several Asia Pacific countries are also playing a crucial role in the market's growth.
Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

Sex reassignment surgery industry size was USD 722.2 million in 2023 and will grow at 11.4% CAGR between 2024 and 2032, fueled by increased societal acceptance of transgender individuals, advancements in surgical techniques, and growing awareness of gender dysphoria.

The male to female segment garnered USD 369.9 million in 2023, attributed to a higher number of individuals seeking transition compared to female-to-male procedures.

North America sex reassignment surgery industry will register an 8.4% CAGR through 2032, driven by advanced healthcare infrastructure, increasing acceptance of transgender rights, and comprehensive insurance coverage.

Asia Cosmetic Hospital, Brigham and Womens Hospital, Kamol Hospital, Nirunda International Aesthetic Clinic, Phuket Plastic Surgery Institute, Rumer Cosmetic Surgery, Sava Perovic Foundation Surgery, Vancouver Coastal Health, Yanhee International Hospital, and Yeson Voice Center

Sex Reassignment Surgery Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 16
  • Tables & Figures: 33
  • Countries covered: 30
  • Pages: 109
 Download Free Sample